Amneal Pharmaceuticals Inc
NYSE:AMRX
ROE
Return on Equity
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
ROE Across Competitors
ROE Comparison
Amneal Pharmaceuticals Inc Competitors
Country | US |
Market Cap | 1.8B USD |
ROE |
-53%
|
Country | JP |
Market Cap | 776 550.9T JPY |
ROE |
-441%
|
Country | US |
Market Cap | 683.6B USD |
ROE |
49%
|
Country | DK |
Market Cap | 3.9T DKK |
ROE |
88%
|
Country | UK |
Market Cap | 440.4B GBP |
ROE |
-4%
|
Country | JP |
Market Cap | 82T JPY |
ROE |
1%
|
Country | US |
Market Cap | 352.4B USD |
ROE |
56%
|
Country | US |
Market Cap | 326.9B USD |
ROE |
1%
|
Country | UK |
Market Cap | 185.4B GBP |
ROE |
16%
|
Country | CH |
Market Cap | 183.9B CHF |
ROE |
28%
|
Country | CH |
Market Cap | 174.8B CHF |
ROE |
40%
|
Profitability Report
View the profitability report to see the full profitability analysis for Amneal Pharmaceuticals Inc.
See Also
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
Based on Amneal Pharmaceuticals Inc's most recent financial statements, the company has ROE of -52.8%.